MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 2 filers reported holding MYOVANT SCIENCES LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,525,000 | +346.2% | 154,800 | +303.1% | 0.02% | +300.0% |
| Q1 2021 | $790,000 | -26.0% | 38,400 | -81.3% | 0.00% | -42.9% |
| Q3 2019 | $1,067,000 | -86.2% | 205,200 | -76.0% | 0.01% | -82.5% |
| Q2 2019 | $7,733,000 | +516.2% | 854,486 | +953.6% | 0.04% | +566.7% |
| Q3 2017 | $1,255,000 | – | 81,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |